2-218073335-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_198483.4(RUFY4):c.479A>T(p.Glu160Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000695 in 1,583,716 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E160D) has been classified as Likely benign.
Frequency
Consequence
NM_198483.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RUFY4 | NM_198483.4 | c.479A>T | p.Glu160Val | missense_variant | 7/13 | ENST00000697321.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RUFY4 | ENST00000697321.1 | c.479A>T | p.Glu160Val | missense_variant | 7/13 | NM_198483.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152108Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000140 AC: 2AN: 1431490Hom.: 0 Cov.: 33 AF XY: 0.00000141 AC XY: 1AN XY: 708926
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152226Hom.: 1 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | The c.479A>T (p.E160V) alteration is located in exon 7 (coding exon 5) of the RUFY4 gene. This alteration results from a A to T substitution at nucleotide position 479, causing the glutamic acid (E) at amino acid position 160 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at